Genmab reports $14.35 billion in DARZALEX sales for 2025

Go back to Genmab reports $14.35 billion in DARZALEX sales for 2025
(NASDAQ: GMAB) Delayed: 35.32 +0.49 (1.41%)
Previous Close $34.83    52 Week High $ 
Open $34.95    52 Week Low $ 
Day High $35.47    P/E N/A 
Day Low $34.70    EPS $ 
Volume 3,583,183